Enrica Cavedo

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Educational attainment, electroencephalographic rhythms, cortical structure, and cognitive performance over 2 years in older adults with subjective memory complaints and brain amyloidosis.

Educational attainment, electroencephalographic rhythms, cortical structure, and cognitive performance over 2 years in older adults with subjective memory complaints and brain amyloidosis.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 07, 2025

Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial.

Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial.

Journal: Aging clinical and experimental research

Published: December 22, 2024

Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.

Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: April 19, 2024

Long-term effects of SARS-CoV-2 infection in patients with and without chemosensory disorders at disease onset: a psychophysical and magnetic resonance imaging exploratory study.

Long-term effects of SARS-CoV-2 infection in patients with and without chemosensory disorders at disease onset: a psychophysical and magnetic resonance imaging exploratory study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: October 27, 2023

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment.

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment.

Journal: Alzheimer's research & therapy

Published: October 14, 2023

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study.

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study.

Journal: Alzheimer's research & therapy

Published: September 14, 2022

Differential response to donepezil in MRI subtypes of mild cognitive impairment.

Differential response to donepezil in MRI subtypes of mild cognitive impairment.

Journal: Alzheimer's research & therapy

Published: September 02, 2022

Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease.

Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 09, 2022

Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.

Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.

Journal: NeuroImage. Clinical

Published: July 28, 2021

Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.

Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.

Journal: Neurology

Published: June 17, 2021

Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®.

Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®.

Journal: European radiology

Published: December 07, 2020

White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.

White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.

Journal: Journal of Alzheimer's disease : JAD

Published: November 30, 2020

Showing 1-12 of 78

Last Updated: 09/26/2026